Fusarial skin lesion in immunocompromised

Indian Journal of Cancer

Volumn 48, Issue 1, 2011, Pages 116-117

  Gurusidappa, S B ^a   Mamatha, H S ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CEFUROXIME; KETOCONAZOLE; TOBRAMYCIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTHRITIS; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; FEVER; FUSARIOSIS; FUSARIUM OXYSPORUM; HEMATOMA; HUMAN; IMMUNOCOMPROMISED PATIENT; KNEE INJURY; LETTER; MALE; POSTTRAUMATIC ARTHROPATHY; PRESCHOOL CHILD; X RAY;

ANTIFUNGAL AGENTS; CHILD; FUNGEMIA; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; SKIN DISEASES;

EID: 79951974198     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.76633     Document Type: Letter

References (4)

1. Anaisie E, Kantarajan H, Ro J, Hopfer R, Rolston K, Fainstein V, et al. The emerging role of fusarium infections in patients with cancer. Medicine 1988;67:77-83.
2. Girmenia C, Pagano L, Corvatta L, Mele L, Del A, Favero, et al. The Epidemiology Of Fusarioses In Patients With Haematological Diseases. Br J Haematol 2000;111:272-6.
3. Musa MO, Al Eisa A, Halim M, Sahovic E, Gyger M, Chaudhri N, et al. The spectrum of fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients; A single institution experience over 10 years. Br J Haematol 2000;108:544-8. (Pubitemid 30196251)
4. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with haematological malignancies: Ten years experience at a cancer centre and implications for management. Blood 1997;90:999-1008. (Pubitemid 27314133)